Pure H20 Bio-Technologies, Inc. Announces New Stock Symbol PRHB, Stock Transfer Agent and Reverse Split of Its Common Stock
November 13 2006 - 5:00AM
Business Wire
Pure H20 Bio-Technologies, Inc. (PINK SHEETS: PRHB), today
announces it duly appoints Continental Stock Transfer and Trust
Company, located at 17 Battery Place, New York, New York, as the
Exchange Agent for its approved reverse split of the Company's
Common Stock. On November 3, 2006 the shareholders of the company
approved a 1- for-1,000 (1:1,000) reverse stock split of the
Company's Common Stock. The reverse split became effective today
upon the filing of the company's Certificate of Amendment to the
Articles of Incorporation of Pure H20 Bio-Technologies, Inc., with
the Florida Secretary of State. The reorganization will be
effective at the open of the market today and the new stock symbol
is "PRHB" and the Cusip Number is: 746223205. The distribution of
the post-split common shares are payable upon surrender of the
pre-split common shares. "For each one thousand (1,000) shares of
pre-split common stock held a shareholder will receive one (1)
share of post-split common stock. No fractional shares or script
representing fractions of a share shall be issued, but in lieu
thereof, each fraction of a share that any Stockholder would
otherwise be entitled to receive shall be rounded up to the nearest
whole share and no additional script or payment made," as stated in
the Company's Articles of Amendment. About PRHB: PRHB is a publicly
held company specializing in the research, development and
commercialization of its unique residential, commercial and
hospital water disinfection systems. The company intends to
commence the manufacture and distribution of its products through a
network of independent distributors. The foregoing press release
contains forward-looking statements that can be identified by such
terminology as expects, potential, suggests, may, intends, or
similar expressions. Such forward-looking statements involve known
risks, uncertainties, and other factors that may cause the actual
results to be materially different from any future results,
performance or achievements expressed or implied by such
statements. In particular, management expectations regarding future
research, development, and or commercial results could be affected
by, among other things, uncertainties relating to the availability
of future financing, unexpected regulatory delays or government
regulation generally, the company's ability to obtain or maintain
patent and other proprietary intellectual protection, and
competition in general. Forward-looking statements speak only as to
the date they are made. The Company does not undertake to update
forward-looking statements to reflect circumstances or events that
occur after the date the forward-looking statements are made. Pure
H20 Bio-Technologies, Inc. (PINK SHEETS: PRHB), today announces it
duly appoints Continental Stock Transfer and Trust Company, located
at 17 Battery Place, New York, New York, as the Exchange Agent for
its approved reverse split of the Company's Common Stock. On
November 3, 2006 the shareholders of the company approved a 1-
for-1,000 (1:1,000) reverse stock split of the Company's Common
Stock. The reverse split became effective today upon the filing of
the company's Certificate of Amendment to the Articles of
Incorporation of Pure H20 Bio-Technologies, Inc., with the Florida
Secretary of State. The reorganization will be effective at the
open of the market today and the new stock symbol is "PRHB" and the
Cusip Number is: 746223205. The distribution of the post-split
common shares are payable upon surrender of the pre-split common
shares. "For each one thousand (1,000) shares of pre-split common
stock held a shareholder will receive one (1) share of post-split
common stock. No fractional shares or script representing fractions
of a share shall be issued, but in lieu thereof, each fraction of a
share that any Stockholder would otherwise be entitled to receive
shall be rounded up to the nearest whole share and no additional
script or payment made," as stated in the Company's Articles of
Amendment. About PRHB: PRHB is a publicly held company specializing
in the research, development and commercialization of its unique
residential, commercial and hospital water disinfection systems.
The company intends to commence the manufacture and distribution of
its products through a network of independent distributors. The
foregoing press release contains forward-looking statements that
can be identified by such terminology as expects, potential,
suggests, may, intends, or similar expressions. Such
forward-looking statements involve known risks, uncertainties, and
other factors that may cause the actual results to be materially
different from any future results, performance or achievements
expressed or implied by such statements. In particular, management
expectations regarding future research, development, and or
commercial results could be affected by, among other things,
uncertainties relating to the availability of future financing,
unexpected regulatory delays or government regulation generally,
the company's ability to obtain or maintain patent and other
proprietary intellectual protection, and competition in general.
Forward-looking statements speak only as to the date they are made.
The Company does not undertake to update forward-looking statements
to reflect circumstances or events that occur after the date the
forward-looking statements are made.
Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Jul 2023 to Jul 2024